{"pageContent": "Introduction: Active surveillance for low risk prostate cancer has become an acceptable management strategy. However, a percentage of these patients in active surveillance move on to active treatment. Our aim was to examine urinary incontinence (UI) rates in men who move on to treatment from active surveillance and compare it to quoted rates in the literature. We examined the question that a potential delay in the treatment of prostate cancer in those on active surveillance may result in an increase in incontinence rates.", "metaData": {"source": "Pathology of prostate cancer and focal therapy ('male lumpectomy')\nhttps://pubmed.ncbi.nlm.nih.gov/20044631/"}}